ENTRY       5605              CDS       T01001
NAME        MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2
DEFINITION  (RefSeq) mitogen-activated protein kinase kinase 2
ORTHOLOGY   K04369  mitogen-activated protein kinase kinase 2 [EC:2.7.12.2]
ORGANISM    hsa  Homo sapiens (human)
PATHWAY     hsa01521  EGFR tyrosine kinase inhibitor resistance
            hsa01522  Endocrine resistance
            hsa04010  MAPK signaling pathway
            hsa04012  ErbB signaling pathway
            hsa04014  Ras signaling pathway
            hsa04015  Rap1 signaling pathway
            hsa04022  cGMP-PKG signaling pathway
            hsa04024  cAMP signaling pathway
            hsa04066  HIF-1 signaling pathway
            hsa04068  FoxO signaling pathway
            hsa04071  Sphingolipid signaling pathway
            hsa04072  Phospholipase D signaling pathway
            hsa04140  Autophagy - animal
            hsa04150  mTOR signaling pathway
            hsa04151  PI3K-Akt signaling pathway
            hsa04210  Apoptosis
            hsa04218  Cellular senescence
            hsa04270  Vascular smooth muscle contraction
            hsa04370  VEGF signaling pathway
            hsa04371  Apelin signaling pathway
            hsa04540  Gap junction
            hsa04550  Signaling pathways regulating pluripotency of stem cells
            hsa04620  Toll-like receptor signaling pathway
            hsa04650  Natural killer cell mediated cytotoxicity
            hsa04660  T cell receptor signaling pathway
            hsa04662  B cell receptor signaling pathway
            hsa04664  Fc epsilon RI signaling pathway
            hsa04720  Long-term potentiation
            hsa04722  Neurotrophin signaling pathway
            hsa04730  Long-term depression
            hsa04810  Regulation of actin cytoskeleton
            hsa04910  Insulin signaling pathway
            hsa04912  GnRH signaling pathway
            hsa04915  Estrogen signaling pathway
            hsa04916  Melanogenesis
            hsa04917  Prolactin signaling pathway
            hsa04919  Thyroid hormone signaling pathway
            hsa04921  Oxytocin signaling pathway
            hsa04926  Relaxin signaling pathway
            hsa05020  Prion diseases
            hsa05161  Hepatitis B
            hsa05164  Influenza A
            hsa05165  Human papillomavirus infection
            hsa05167  Kaposi's sarcoma-associated herpesvirus infection
            hsa05200  Pathways in cancer
            hsa05205  Proteoglycans in cancer
            hsa05206  MicroRNAs in cancer
            hsa05211  Renal cell carcinoma
            hsa05213  Endometrial cancer
            hsa05214  Glioma
            hsa05215  Prostate cancer
            hsa05216  Thyroid cancer
            hsa05218  Melanoma
            hsa05219  Bladder cancer
            hsa05220  Chronic myeloid leukemia
            hsa05221  Acute myeloid leukemia
            hsa05223  Non-small cell lung cancer
            hsa05224  Breast cancer
            hsa05230  Central carbon metabolism in cancer
            hsa05231  Choline metabolism in cancer
MODULE      hsa_M00687  MAPK (ERK1/2) signaling
DISEASE     H00523  Noonan syndrome and related disorders
DRUG_TARGET Binimetinib: D10604
            Cobimetinib (DG01825): D10405 D10615
            Pimasertib (DG01410): D10426 D10486
            Selumetinib (DG01414): D09666 D10024
            Trametinib (DG00723): D10175 D10176
BRITE       KEGG Orthology (KO) [BR:hsa00001]
             Environmental Information Processing
              Signal transduction
               04014 Ras signaling pathway
                5605 (MAP2K2)
               04015 Rap1 signaling pathway
                5605 (MAP2K2)
               04010 MAPK signaling pathway
                5605 (MAP2K2)
               04012 ErbB signaling pathway
                5605 (MAP2K2)
               04370 VEGF signaling pathway
                5605 (MAP2K2)
               04371 Apelin signaling pathway
                5605 (MAP2K2)
               04066 HIF-1 signaling pathway
                5605 (MAP2K2)
               04068 FoxO signaling pathway
                5605 (MAP2K2)
               04072 Phospholipase D signaling pathway
                5605 (MAP2K2)
               04071 Sphingolipid signaling pathway
                5605 (MAP2K2)
               04024 cAMP signaling pathway
                5605 (MAP2K2)
               04022 cGMP - PKG signaling pathway
                5605 (MAP2K2)
               04151 PI3K-Akt signaling pathway
                5605 (MAP2K2)
               04150 mTOR signaling pathway
                5605 (MAP2K2)
             Cellular Processes
              Transport and catabolism
               04140 Autophagy - animal
                5605 (MAP2K2)
              Cell growth and death
               04210 Apoptosis
                5605 (MAP2K2)
               04218 Cellular senescence
                5605 (MAP2K2)
              Cellular community - eukaryotes
               04540 Gap junction
                5605 (MAP2K2)
               04550 Signaling pathways regulating pluripotency of stem cells
                5605 (MAP2K2)
              Cell motility
               04810 Regulation of actin cytoskeleton
                5605 (MAP2K2)
             Organismal Systems
              Immune system
               04620 Toll-like receptor signaling pathway
                5605 (MAP2K2)
               04650 Natural killer cell mediated cytotoxicity
                5605 (MAP2K2)
               04660 T cell receptor signaling pathway
                5605 (MAP2K2)
               04662 B cell receptor signaling pathway
                5605 (MAP2K2)
               04664 Fc epsilon RI signaling pathway
                5605 (MAP2K2)
              Endocrine system
               04910 Insulin signaling pathway
                5605 (MAP2K2)
               04912 GnRH signaling pathway
                5605 (MAP2K2)
               04915 Estrogen signaling pathway
                5605 (MAP2K2)
               04917 Prolactin signaling pathway
                5605 (MAP2K2)
               04921 Oxytocin signaling pathway
                5605 (MAP2K2)
               04926 Relaxin signaling pathway
                5605 (MAP2K2)
               04919 Thyroid hormone signaling pathway
                5605 (MAP2K2)
               04916 Melanogenesis
                5605 (MAP2K2)
              Circulatory system
               04270 Vascular smooth muscle contraction
                5605 (MAP2K2)
              Nervous system
               04720 Long-term potentiation
                5605 (MAP2K2)
               04730 Long-term depression
                5605 (MAP2K2)
               04722 Neurotrophin signaling pathway
                5605 (MAP2K2)
             Human Diseases
              Cancers
               05200 Pathways in cancer
                5605 (MAP2K2)
               05230 Central carbon metabolism in cancer
                5605 (MAP2K2)
               05231 Choline metabolism in cancer
                5605 (MAP2K2)
               05206 MicroRNAs in cancer
                5605 (MAP2K2)
               05205 Proteoglycans in cancer
                5605 (MAP2K2)
               05214 Glioma
                5605 (MAP2K2)
               05216 Thyroid cancer
                5605 (MAP2K2)
               05221 Acute myeloid leukemia
                5605 (MAP2K2)
               05220 Chronic myeloid leukemia
                5605 (MAP2K2)
               05218 Melanoma
                5605 (MAP2K2)
               05211 Renal cell carcinoma
                5605 (MAP2K2)
               05219 Bladder cancer
                5605 (MAP2K2)
               05215 Prostate cancer
                5605 (MAP2K2)
               05213 Endometrial cancer
                5605 (MAP2K2)
               05224 Breast cancer
                5605 (MAP2K2)
               05223 Non-small cell lung cancer
                5605 (MAP2K2)
              Neurodegenerative diseases
               05020 Prion diseases
                5605 (MAP2K2)
              Infectious diseases
               05164 Influenza A
                5605 (MAP2K2)
               05161 Hepatitis B
                5605 (MAP2K2)
               05167 Kaposi's sarcoma-associated herpesvirus infection
                5605 (MAP2K2)
               05165 Human papillomavirus infection
                5605 (MAP2K2)
              Drug resistance
               01521 EGFR tyrosine kinase inhibitor resistance
                5605 (MAP2K2)
               01522 Endocrine resistance
                5605 (MAP2K2)
            Enzymes [BR:hsa01000]
             2. Transferases
              2.7  Transferring phosphorus-containing groups
               2.7.12  Dual-specificity kinases (those acting on Ser/Thr and Tyr residues)
                2.7.12.2  mitogen-activated protein kinase kinase
                 5605 (MAP2K2)
            Protein kinases [BR:hsa01001]
             Serine/threonine protein kinases: STE group
              STE7 family
               5605 (MAP2K2)
POSITION    19p13.3
MOTIF       Pfam: Pkinase Pkinase_Tyr Kinase-like Haspin_kinase APH Seadorna_VP7 Kdo CAMSAP_CC1
DBLINKS     NCBI-GeneID: 5605
            NCBI-ProteinID: NP_109587
            OMIM: 601263
            HGNC: 6842
            Ensembl: ENSG00000126934
            Vega: OTTHUMG00000134286
            Pharos: P36507(Tclin)
            UniProt: P36507
STRUCTURE   PDB: 1S9I
AASEQ       400
            MLARRKPVLPALTINPTIAEGPSPTSEGASEANLVDLQKKLEELELDEQQKKRLEAFLTQ
            KAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQ
            VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG
            LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQ
            GTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP
            PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL
            KMLTNHTFIKRSEVEEVDFAGWLCKTLRLNQPGTPTRTAV
NTSEQ       1203
            atgctggcccggaggaagccggtgctgccggcgctcaccatcaaccctaccatcgccgag
            ggcccatcccctaccagcgagggcgcctccgaggcaaacctggtggacctgcagaagaag
            ctggaggagctggaacttgacgagcagcagaagaagcggctggaagcctttctcacccag
            aaagccaaggtcggcgaactcaaagacgatgacttcgaaaggatctcagagctgggcgcg
            ggcaacggcggggtggtcaccaaagtccagcacagaccctcgggcctcatcatggccagg
            aagctgatccaccttgagatcaagccggccatccggaaccagatcatccgcgagctgcag
            gtcctgcacgaatgcaactcgccgtacatcgtgggcttctacggggccttctacagtgac
            ggggagatcagcatttgcatggaacacatggacggcggctccctggaccaggtgctgaaa
            gaggccaagaggattcccgaggagatcctggggaaagtcagcatcgcggttctccggggc
            ttggcgtacctccgagagaagcaccagatcatgcaccgagatgtgaagccctccaacatc
            ctcgtgaactctagaggggagatcaagctgtgtgacttcggggtgagcggccagctcatc
            gactccatggccaactccttcgtgggcacgcgctcctacatggctccggagcggttgcag
            ggcacacattactcggtgcagtcggacatctggagcatgggcctgtccctggtggagctg
            gccgtcggaaggtaccccatccccccgcccgacgccaaagagctggaggccatctttggc
            cggcccgtggtcgacggggaagaaggagagcctcacagcatctcgcctcggccgaggccc
            cccgggcgccccgtcagcggtcacgggatggatagccggcctgccatggccatctttgaa
            ctcctggactatattgtgaacgagccacctcctaagctgcccaacggtgtgttcaccccc
            gacttccaggagtttgtcaataaatgcctcatcaagaacccagcggagcgggcggacctg
            aagatgctcacaaaccacaccttcatcaagcggtccgaggtggaagaagtggattttgcc
            ggctggttgtgtaaaaccctgcggctgaaccagcccggcacacccacgcgcaccgccgtg
            tga
///
